171 related articles for article (PubMed ID: 7955047)
41. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms in the glutathione S-transferase mu cluster are associated with tumour progression and patient outcome in colorectal cancer.
Holley SL; Rajagopal R; Hoban PR; Deakin M; Fawole AS; Elder JB; Elder J; Smith V; Strange RC; Fryer AA
Int J Oncol; 2006 Jan; 28(1):231-6. PubMed ID: 16328000
[TBL] [Abstract][Full Text] [Related]
43. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Illemann M; Bird N; Majeed A; Sehested M; Laerum OD; Lund LR; Danø K; Nielsen BS
Mol Cancer Res; 2006 May; 4(5):293-302. PubMed ID: 16687484
[TBL] [Abstract][Full Text] [Related]
44. Expression of the glutathione enzyme system of human colon mucosa by localisation, gender and age.
Hoensch H; Peters WH; Roelofs HM; Kirch W
Curr Med Res Opin; 2006 Jun; 22(6):1075-83. PubMed ID: 16846540
[TBL] [Abstract][Full Text] [Related]
45. Effect of long time storage on cytosolic glutathione S-transferases.
Peters WH; Roelofs HM
Biochem Mol Biol Int; 1997 Apr; 41(5):913-7. PubMed ID: 9137821
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas.
Cairns J; Wright C; Cattan AR; Hall AG; Cantwell BJ; Harris AL; Horne CH
J Pathol; 1992 Jan; 166(1):19-25. PubMed ID: 1347080
[TBL] [Abstract][Full Text] [Related]
47. Changes of reduced glutathione and glutathione S-transferase levels in colorectal cancer patients undergoing treatment.
Baltruskeviciene E; Kazbariene B; Aleknavicius E; Krikstaponiene A; Venceviciene L; Suziedelis K; Stratilatovas E; Didziapetriene J
Tumori; 2018 Oct; 104(5):375-380. PubMed ID: 28777429
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
Yusof YA; Yan KL; Hussain SN
Anal Quant Cytol Histol; 2003 Dec; 25(6):332-8. PubMed ID: 14714299
[TBL] [Abstract][Full Text] [Related]
49. Proteomic analysis of differentially expressed proteins involving in liver metastasis of human colorectal carcinoma.
Li SY; An P; Cai HY; Bai X; Zhang YN; Yu B; Zuo FY; Chen G
Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):149-53. PubMed ID: 20382585
[TBL] [Abstract][Full Text] [Related]
50. Glutathione S-transferases in human liver cancer.
Hayes PC; May L; Hayes JD; Harrison DJ
Gut; 1991 Dec; 32(12):1546-9. PubMed ID: 1663474
[TBL] [Abstract][Full Text] [Related]
51. Glutathione S-transferases activity in patients with colorectal cancer.
Nomani H; Ghobadloo SM; Yaghmaei B; Rezvanie NA; Yaghmaei K
Clin Biochem; 2005 Jul; 38(7):621-4. PubMed ID: 15904910
[TBL] [Abstract][Full Text] [Related]
52. Purification and characterization of a new cytosolic glutathione S-transferase (glutathione S-transferase X) from rat liver.
Friedberg T; Milbert U; Bentley P; Guenther TM; Oesch F
Biochem J; 1983 Dec; 215(3):617-25. PubMed ID: 6661188
[TBL] [Abstract][Full Text] [Related]
53. Loss of glutathione S-transferase (GST) mu phenotype in colorectal adenocarcinomas from patients with a GSTM1 positive genotype.
Barker HJ; Alpert LC; Compton CC; Maslen A; Kirby GM
Cancer Lett; 2002 Mar; 177(1):65-74. PubMed ID: 11809532
[TBL] [Abstract][Full Text] [Related]
54. Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Grubben MJ; van den Braak CC; Nagengast FM; Peters WH
Eur J Clin Invest; 2006 Mar; 36(3):188-92. PubMed ID: 16506964
[TBL] [Abstract][Full Text] [Related]
55. Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
Robertson IG; Guthenberg C; Mannervik B; Jernström B
Cancer Res; 1986 May; 46(5):2220-4. PubMed ID: 3084065
[TBL] [Abstract][Full Text] [Related]
56. Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas.
Peters WH; Kock L; Nagengast FM; Roelofs HM
Biochem Pharmacol; 1990 Feb; 39(3):591-7. PubMed ID: 2306270
[TBL] [Abstract][Full Text] [Related]
57. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.
Maurer CA; Graber HU; Friess H; Beyermann B; Willi D; Netzer P; Zimmermann A; Büchler MW
Surgery; 1999 Nov; 126(5):869-80. PubMed ID: 10568187
[TBL] [Abstract][Full Text] [Related]
58. Tissue distribution of enzymic methylation of glutathione S-transferase and its effects on catalytic activity. Methylation of glutathione S-transferase 11-11 inhibits conjugating activity towards 1-chloro-2,4-dinitrobenzene.
Johnson JA; Finn KA; Siegel FL
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):279-89. PubMed ID: 1540144
[TBL] [Abstract][Full Text] [Related]
59. Expression of alpha, mu and pi class glutathione S-transferases in oval and ductal cells in liver of rats placed on a choline-deficient, ethionine-supplemented diet.
Tee LB; Smith PG; Yeoh GC
Carcinogenesis; 1992 Oct; 13(10):1879-85. PubMed ID: 1423848
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical localization of alpha and pi class glutathione transferases in normal human tissues.
Sundberg AG; Nilsson R; Appelkvist EL; Dallner G
Pharmacol Toxicol; 1993; 72(4-5):321-31. PubMed ID: 8372055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
